Alison Kanski

Most Recent Articles by Alison Kanski

Changes at the top of commercial units for Gilead and BMS

Changes at the top of commercial units for Gilead and BMS

By

Christopher Boerner was promoted to lead commercial at BMS, and Laura Hamill joined Gilead from Amgen to head up its commercial operations.

Five things for pharma marketers to know: Wednesday, August 29, 2018

Five things for pharma marketers to know: Wednesday, August 29, 2018

By

Gilead appoints new commercial lead; U.K. bans online ad for contraception app; Pfizer petitions the FDA to clarify biosimilar communications.

After failure of generic fish oil trial, some caution against read-across to Vascepa study

After failure of generic fish oil trial, some caution against read-across to Vascepa study

By

Amarin's Vascepa trial is set to read out results by the end of September.

Five things for pharma marketers to know: Friday, August 24, 2018

Five things for pharma marketers to know: Friday, August 24, 2018

By

White House proposes rule for drug prices in DTC ads; FDA to study impact of side-effects warnings in drug ads; FDA approves Shire's potential blockbuster HAE treatment.

Behind the Exact Sciences/Pfizer Cologuard co-promotion deal

Behind the Exact Sciences/Pfizer Cologuard co-promotion deal

By

The companies plan to make the most of favorable market access conditions for the at-home colon cancer screening test.

More Articles by Alison Kanski